Clinical Trials

The sophistication of clinical trial management continues to advance at an unprecedented pace, and nowhere is this transformation more evident than in clinical packaging and labeling solutions. As trials become increasingly global, complex, and patient-centric, packaging has evolved from...

The clinical research landscape is experiencing a significant paradigm shift toward decentralized and hybrid trial models that fundamentally alter how clinical supplies are managed, distributed, and tracked. Decentralized clinical trials (DCTs), which enable patients to participate from their homes...

Sterile pharmaceutical manufacturing represents one of the most technically demanding and highly regulated aspects of pharmaceutical production. The stakes are exceptionally high—any compromise in sterility assurance can render entire batches unusable or, worse, lead to contaminated products reaching patients...

The clinical research landscape has undergone a fundamental transformation in recent years, with traditional two-arm trial designs giving way to more sophisticated multi-arm and platform trial structures. These complex study designs demand equally sophisticated supply chain strategies that can...

Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...

Datroway, a cancer drug developed by AstraZeneca and Daiichi Sankyo, has demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in the TROPION-Breast02 Phase III trial. The...

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...